Memberships

MetrioPharm

MetrioPharm Memberships

News

MetrioPharm AG Expands Patent Protection for its Lead Compound MP1032 to Canada - 2018-Nov-15

MetrioPharm AG announces that a substance patent for its lead compound MP1032 has been obtained in Canada. The Canadian patent CA 2791327 was granted on October 30, 2018.

» more

Investor Relations

MetrioPharm Investor Relations News QIII 2018 - 2018-Sep-27

Topics: Update on the ongoing Phase-II-study, MetrioPharm in Stockholm, Investor Talks in New York, Herbstkonferenz in Frankfurt, Company Calendar

» more

Navigation

Home
About us
Technology
Pipeline
Investors
Press
Contact
Blog

Social

  

Newsletter

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Switzerland (HQ)

MetrioPharm AG

Bleicherweg 45
8002 Zurich

Phone: +41 (44) 515 21 97

Germany (R&D)

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin

Phone: +49 (0)30 – 3384 395 02

Imprint
Privacy policy
Sitemap